Late-stage drug failures drive toxicology testing market growth
Drug Discovery World
FEBRUARY 26, 2024
The global ADME toxicology testing market is predicted to generate a revenue of $19.21 billion by 2030, with a growth rate of 10.2%. Factors such as an increased need to check late-stage drug failures with the adoption of more appropriate toxicity testing methods by pharmaceutical companies are expected to aid revenue generation for the market. The predictions are made by ResearchAndMarkets.com in a new market report entitled ‘ADME Toxicology Testing Market Size, Share & Trends Analysis Repo
Let's personalize your content